"At GenesisCare, we offer multidisciplinary personalised cancer treatments based on the needs of our patients as individuals. Our focus is on building relationships with humans that get us talked about long after treatment ends. We're an organisation with a local, national and global presence, providing care where it's needed. Our radiation and medical oncologists are among the world's leading specialists in the treatment of cancer. We invest in innovative treatments, advanced technologies and clinical trials with the goal to continually improve patient outcomes. Our services include radiation oncology, medical oncology and theranostics."

During the past decade, Genesis Cancer Care Newcastle conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Genesis Cancer Care Newcastle" #1 collaborator was "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Cancer Trials Ireland" with 1 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator and "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Genesis Cancer Care Newcastle" are "Early Stage Breast Carcinoma" (1 trials) and "Prostatic Neoplasms" (1 trials). Many other conditions were trialed in "Genesis Cancer Care Newcastle" in a lesser frequency.

Most popular intervention types in "Genesis Cancer Care Newcastle" are "Radiation" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Conventional NSAA" (1 trials), "Enzalutamide" (1 trials), "External Beam Radiotherapy (78 Gy in 39 fractions or 46 Gy in 23 fractions plus brachytherapy boost)" (1 trials), "LHRHA" (1 trials) and "Omission of radiation therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Genesis Cancer Care Newcastle" are 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Genesis Cancer Care Newcastle". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Genesis Cancer Care Newcastle, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Genesis Cancer Care Newcastle, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".